SMP-986 Phase 2 Proof of Concept in Patients With Overactive Bladder Syndrome (OABS)
Public ClinicalTrials.gov record NCT00409539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 10-week Randomised, DB, PG, PC Phase 2 Study to Investigate the Extent of Symptom Relief and the Safety and Tolerability of SMP-986 (20, 40, 80 and 120 mg) Administered Once Daily for 8 Weeks to Patients With Overactive Bladder Syndrome
Study identification
- NCT ID
- NCT00409539
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Industry
- Enrollment
- 550 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- SMP-986 Drug
Drug
Eligibility (public fields only)
- Age range
- 20 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2006
- Primary completion
- May 31, 2008
- Completion
- Jun 30, 2008
- Last update posted
- Dec 9, 2014
2006 – 2008
United States locations
- U.S. sites
- 21
- U.S. states
- 13
- U.S. cities
- 21
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Visions Clinical Research | Tuscon | Arizona | 85712 | — |
| Peninsula Urology Center | Atherton | California | 94027 | — |
| San Bernadino Urological Association Medical Group | San Bernadino | California | 92404 | — |
| 9040 Friars Road | San Diego | California | 92108 | — |
| South Florida Medical Research | Aventura | Florida | 33180 | — |
| Visions Clinical Research | Boynton Beach | Florida | 33437 | — |
| Florida Healthcare Research | Ocala | Florida | 34474 | — |
| Southern Research Group, Centre Point Boulevard | Tallahassee | Florida | 32308 | — |
| Atlanta Medical Research | Alpharetta | Georgia | 30005 | — |
| Urological Surgeons of IL | Kankakee | Illinois | 60901 | — |
| Regional Urology | Shreveport | Louisiana | 71106 | — |
| Accumed Research Associate | Garden City | New York | 11530 | — |
| Hudson Valley Urology | Kingston | New York | 12401 | — |
| New York Urological Associates, PC | New York | New York | 10022 | — |
| Hudson Valley Urology | Poughkeepsie | New York | 12601 | — |
| Unifour Medical Research | Hickory | North Carolina | 28601 | — |
| University of Pittsburg, Dept Urology | Pittsburgh | Pennsylvania | 15213 | — |
| Volunteer Research Group | Knoxville | Tennessee | 37920 | — |
| 5920 Saratoga Boulevard | Corpus Christi | Texas | 78414 | — |
| National Clinical Research Inc | Richmond | Virginia | 23294 | — |
| 801 W. 5th Avenue | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00409539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 9, 2014 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00409539 live on ClinicalTrials.gov.